90 filings
Page 3 of 5
8-K
btvl5r8zy33
9 Aug 22
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
12:00am
EFFECT
1m9bajclpwbu4c81xo
8 Jul 22
Notice of effectiveness
12:15am
CORRESP
ixu2vbph5a55j
5 Jul 22
Correspondence with SEC
12:00am
8-K
k21xu
28 Jun 22
Regulation FD Disclosure
6:17pm
UPLOAD
huc8b u9q
27 Jun 22
Letter from SEC
12:00am
S-3
ngcn0a
22 Jun 22
Shelf registration
12:21pm
8-K
igyuexuh 4hch1m9
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K/A
jwwdsss pzssslu
24 May 22
Financial Statements and Exhibits
7:31am
DEFR14A
v9l72ca
13 May 22
Revised proxy
4:03pm
8-K
98b oc9lg083ork5qqfc
13 May 22
Changes in Registrant's Certifying Accountant
4:02pm
8-K
rhqlk0qdw3 kvw
11 May 22
Vaccitech Reports First Quarter 2022 Financial Results and Recent Corporate Developments
4:25pm
DEF 14A
jikfnwy140m ah9x4
2 May 22
Definitive proxy
8:48am
S-8
cv7lp
25 Mar 22
Registration of securities for employees
8:00am
10-K
meho0hs8b480g
25 Mar 22
Annual report
7:43am
8-K
gyjfm3 e7dbqpfjdkmb
25 Mar 22
Vaccitech Reports Full-Year 2021 Financial Results and Recent Corporate Developments
7:25am
8-K
7p42rce5298hr5f
14 Dec 21
Vaccitech acquires Avidea Technologies to expand product pipeline and strengthen scientific leadership in immunotherapies and vaccines
5:15pm